The disadvantages of jinhe biotechnology co., ltd.

COVID-19 epidemic. The disadvantages of Jinhe Biotechnology Co., Ltd. are as follows:

1. First of all, the COVID-19 epidemic led to a decline in overseas sales of chlortetracycline.

2. Secondly, the latest policy leads to a decline in domestic sales, but in the long run, it is beneficial to the sales of chlortetracycline.

3. Then RMB appreciated, resulting in a lot of exchange losses.

4. Finally, corn raw materials appreciate, and thermal coal prices rise.